Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study-Reference-Cited by-同舟云学术

Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study

Published:2016-12 Issue:6 Volume:7 Page:860-874
ISSN:2078-6891
Container-title:Journal of Gastrointestinal Oncology
language:
Short-container-title:J. Gastrointest. Oncol.

Author:

Fidelman Nicholas,Kerlan Jr Robert K.,Hawkins Randall A.,Pampaloni Miguel,Taylor Andrew G.,Kohi Maureen P.,Kolli K. Pallav,Atreya Chloe E.,Bergsland Emily K.,Kelley R. Kate,Ko Andrew H.,Korn W. Michael,Van Loon Katherine,McWhirter Ryan M.,Luan Jennifer,Johanson Curt,Venook Alan P.

Publisher

AME Publishing Company

Subject

Gastroenterology,Oncology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal patient selection for yttrium-90 glass plus chemotherapy in the treatment of colorectal liver metastases: additional quality of life, efficacy, and safety analyses from the EPOCH study;The Oncologist;2024-07-10

2. Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases;BMC Cancer;2022-12-13

3. Phase I Prospective Trial of TAS-102 (trifluridine and tipiracil) and Radioembolization with 90 Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases;2022-09-20

4. Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes;Journal of Nuclear Medicine;2022-06-23

5. Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies;Cancers;2022-02-28